PMGC HOLDINGS INC. Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal
PMGC HOLDINGS INC. (ELAB) reported Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal of $30.97 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal · last filed 2026-03-30
- PMGC HOLDINGS INC. discontinued operation, tax (expense) benefit from provision for (gain) loss on disposal for fiscal 2025 was $30.97K.
| Period end | Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal 12 month |
|---|---|
| 2025-12-31 | $30.97K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |